We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Some PET Drugs May be Exempt From NDA Requirement, Guidance Says
Some PET Drugs May be Exempt From NDA Requirement, Guidance Says
February 17, 2012
The FDA may allow use of an expanded access IND in place of an NDA for certain positron emission tomography (PET) drugs currently in clinical use, according to a draft guidance.